|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03010020 |
|
Date of registration:
|
01/01/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
STI Screening as a Combined HIV Prevention Platform for MSM in Peru
|
|
Scientific title:
|
STI Screening as a Combined HIV Prevention Platform for MSM in Peru |
|
Date of first enrolment:
|
July 15, 2017 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03010020 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Peru
| | | | | | | |
|
Contacts
|
|
Name:
|
Jesse L Clark, MD, MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of California, Los Angeles |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 18 years of age or older
- Assigned male sex at birth
- HIV-uninfected
- Reports receptive anal intercourse with an HIV-infected or unknown serostatus partner
within the previous 6 months
- Diagnosed with rectal gonorrhea and/or chlamydia infection (not applicable to
GC/CT-uninfected controls)
Exclusion Criteria:
- Unable to complete informed consent procedures
- HIV-infected (according to laboratory testing)
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Chlamydia of Rectum
|
|
Gonorrhoea of Rectum
|
|
HIV Infections
|
|
Intervention(s)
|
|
Behavioral: PCC
|
|
Behavioral: Traditional Counseling
|
|
Primary Outcome(s)
|
|
Unprotected Receptive Anal Intercourse (URAI) with Serodiscordant or Unknown Serostatus Partner
[Time Frame: 6 Months]
|
|
Secondary Outcome(s)
|
|
Persistent or Recurrent Rectal GC/CT Infection
[Time Frame: 6 Months]
|
|
Inflammatory Cytokine Levels in Rectal Mucosa
[Time Frame: 6 Months]
|
|
Secondary ID(s)
|
|
R34MH105272
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|